Join to View Full Profile
1515 Holcombe BlvdUnit 423Houston, TX 77030
Phone+1 713-794-5745
Fax+1 713-794-4902
Dr. Bashir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2006 - 2009
University of Missouri-ColumbiaResidency, Internal Medicine, 2003 - 2006
King Edward Medical UniversityClass of 2001
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
GA State Medical License 2023 - 2027
TN State Medical License 2023 - 2027
TX State Medical License 2009 - 2027
LA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
Clinical Trials
- Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT) Start of enrollment: 2014 Jan 01
- Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation Start of enrollment: 2019 Oct 09
Publications & Presentations
PubMed
- Lenalidomide maintenance after delayed or salvage autologous stem cell transplantation.Asad A Haider, Curtis Marcoux, Denái R Milton, Mark R Tanner, Qaiser Bashir
Leukemia & Lymphoma. 2026-01-29 - Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single...Betül Oran, Peter Thall, Amin Alousi, Gheath Al-Atrash, Rohtesh Mehta
Haematologica. 2026-01-01 - Post-transplant outcomes in IgD multiple myeloma:a propensity score-matched analysis.Curtis Marcoux, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer Srour
Transplantation and Cellular Therapy. 2025-12-18
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
- Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature
Press Mentions
Busulfan Added to Conditioning Regimen Effective for Newly Diagnosed MyelomaMay 20th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
